Human immunodeficiency virus-associated peripheral neuropathies

Mayo Clinic Proceedings

Volumn 81, Issue 2, 2006, Pages 213-219

  Ferrari, Sergio ^a   Vento, Sandro ^a   Monaco, Salvatore ^a   Cavallaro, Tiziana ^a   Cainelli, Francesca ^b   Rizzuto, Nicolo ^a   Temesgen, Zelalem ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Infectious Diseases Unit   (Italy)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; CAPSAICIN; CIDOFOVIR; CORTICOSTEROID; DESIPRAMINE; DIDANOSINE; FENTANYL; FOSCARNET; GABAPENTIN; GANCICLOVIR; IMMUNOGLOBULIN; INDINAVIR; LAMOTRIGINE; LIDOCAINE; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PREDNISONE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALCITABINE;

CYTOMEGALOVIRUS INFECTION; DIFFUSE INFILTRATIVE LYMPHOCYTOSIS SYNDROME; DISTAL SYMMETRICAL POLYNEUROPATHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOSIS; METABOLIC DISORDER; MONONEURITIS SIMPLEX; MONONEUROPATHY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; RADICULOPATHY; REVIEW; VASCULITIS;

EID: 32144458459     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.2.213     Document Type: Review

References (69)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al, HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
2. Manji H. Neuropathy in HIV infection. Curr Opin Neurol. 2000;13:589-592.
3. Manji H, Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatry. 2004;75(suppl 1):i29-i35.
4. So YT, Holtzman DM, Abrams DI, Olney RK. Peripheral neuropathy associated with acquired immunodeficency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol. 1988;45:945-948.
5. Griffin JW, Crawford TO, Tyor WR, et al. Predominantly sensory neuropathy in AIDS: distal axonal degeneration and unmyelinated fiber loss [abstract]. Neurology. 1991;41(suppl 1):374. Abstract 900S.
6. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000;69:376-380.
7. Morgello S, Estanislao L, Simpson D, et al, Manhattan HIV Brain Bank. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004;61:546-551.
8. Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD, HIV Outpatient Study Investigators. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis. 2005;40:148-157.
9. Comblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988;38:794-796.
10. de la Monte SM, Gabuzda DH, Ho DD, et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol. 1988;23:485-492.
11. Griffin JW, Crawford TO, McArthur JC. Peripheral neuropathies associated with HIV infection. In: Gendelman HE, Epstein E, Lipton SA, Swindells S, eds. The Neurology of AIDS. New York, NY: Chapman & Hall; 1998:275-291.
12. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985;313:1493-1497.
13. Rizzuto N, Cavallaro T, Monaco S, et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol (Berl). 1995;90:244 250.
14. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:153-161.
15. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1:417-422.
16. Gherardi RK, Chrétien F, Delfau-Larue MH, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology. 1998;50:1041-1044.
17. Verma S, Estanislao L, Mintz L, Simpson D. Controlling neuropathic pain in HIV. Curr Infect Dis Rep. 2004;6:237-242.
18. Hahn K, Arendt G, Braun JS, et al, German Neuro-AIDS Working Group. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol 2004;251:1260-1266.
19. Simpson DM, McArthur JC, Olney R, et al, Lamotrigine HIV Neuropathy Study Team. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003;60:1508-1514.
20. Estanislao L, Carter K, McArthur J, Olney R, Simpson D, Lidoderm-HIV Neuropathy Group. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr. 2004;37:1584-1586.
21. McArthur JC, Yiannoutsos C, Simpson DM, et al, AIDS Clinical Trials Group Team 291. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection [published correction appears in Neurology. 2000;55:162]. Neurology. 2000;54:1080-1088.
22. Shlay JC, Chaloner K, Max MB, et al, Terry Beim Community Programs for Clinical Research on AIDS. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA. 1998;280:1590-1595.
23. Fichtenbaum CJ, Clifford DB, Powderly WG. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:169-174.
24. Moyle GJ, Sadler M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors,incidence and management. Drug Saf. 1998;19:481-494.
25. Crabb C. Protease inhibitors and risk of developing HIV-related sensory neuropathy. AIDS. 2004;18:N10.
26. Marcus K, Truffa M, Boxwell D, Toerner J. Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: cases from the FDA's adverse event reporting system (AERS). In: Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections; February 24-28, 2002; Seattle, Wash. Abstract LB14.
27. Simpson D, Estanislao L, Evans S, et al, HIV Neuromuscular Syndrome Study Group. HIV-associated neuromuscular weakness syndrome [published correction appears in AIDS. 2004;18:1751]. AIDS. 2004;18:1403-1412.
28. Berger JR, Simpson DM. The pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS-related peripheral neuropathy [editorial]. Neurology. 1998;50:855-857.
29. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997;41:438-445.
30. Mishra BB, Sommers W, Koski CL, Greenstein JI. Acute inflammatory demyelinating polyneuropathy in the acquired immune deficiency syndrome [abstract]. Ann Neurol. 1985;18:131-132. Abstract P49.
31. Comblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987;21:32-40.
32. Piette AM, Tusseau F, Vignon D, et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III [letter]. Lancet. 1986;1:852.
33. Vendrell J, Heredia C, Pujol M, Vidai J, Blesa R, Graus F. Guillain-Barré syndrome associated with seroconversion for anti-HTLV-III [letter]. Neurology. 1987;37:544.
34. Thornton CA, Latif AS, Emmanuel JC. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology. 1991;41:812-815.
35. Brannagan TH III, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003;208:39-42.
36. Comblath DR. Treatment of the neuromuscular complications of human immunodeficiency virus infection. Ann Neurol. 1988;23(suppl):S88-S91.
37. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983;14:403-418.
38. So YT, Olney RK, The natural history of mononeuropathy multiplex and simplex in patients with HIV infection [abstract]. Neurology. 1991;41(suppl 1):375. Abstract 902S.
39. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol. 1991;29:139-146.
40. Caniatti LM, Tugnoli V, Eleopra R, Tralli G, Bassi R, De Grandis D. Cryoglobulinemic neuropathy related to hepatitis C virus infection: clinical, laboratory and neurophysiological study. J Peripher Nerv Syst. 1996;1:131-138.
41. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol. 2001;54:275-278.
42. Fuller GN, Jacobs JM, Guiloff RJ. Nature and incidence of peripheral nerve syndromes in HTV infection. J Neurol Neurosurg Psychiatry. 1993;56:372-381.
43. Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-infection: relief of pain with prednisone therapy. Neurology. 1996;47:1446-1451.
44. Ferrari S, Lanzafame M, Faggian F, et al. Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. Scand J Infect Dis. 2004;36:392-393.
45. Eidelberg D, Sostrel A, Vogel H, Walker P, Kleefield J, Crumpacker CS III. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology. 1986;36:912-916.
46. Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr. 1992;5(suppl 1):S33-S36.
47. Behar R, Wiley C, McCutchan JA. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology. 1987;37:557-561.
48. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992;14:608-615.
49. Leger JM, Henin D, Belec L, et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol. 1992;239:132-134.
50. Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology. 1988;38:1297-1301.
51. Berger JR. Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy. Am J Med. 1992;92:101-103.
52. Woolsey RM, Chambers TJ, Chung HD, McGary JD. Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol. 1988;45:691-693.
53. Corral I, Quereda C, Casado JL, et al. Acute polyradiculopathies in HIV-infected patients. J Neurol. 1997;244:499-504.
54. Miller RF.Fox JD, Waite JC, Severn A, Brink NS. Herpes simplex virus type 2 encephalitis and concomitant cytomegalovirus infection in a patient with AIDS: detection of virus-specific DNA in CSF by nested polymerase chain reaction. Genitourin Med. 1995;71:262-264.
55. Wiley CA, VanPatten PD, Carpenter PM, Powel HC, Thai LJ. Acute ascending necrotizing myelopathy caused by herpes simplex viras type 2. Neurology. 1987;37:1791-1794.
56. Dromer F, Mouligner A, Dupont B, et al. Myeloradiculitis due to Cryptococcus curvatus in AIDS [letter]. AIDS. 1995;9:395-396.
57. Miller RF, Fox JD, Thomas P, et al. Acute lumbosacral polyradiculopathy due to cytomegaloviras in advanced HTV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry. 1996;61:450-460.
58. Cinque P, Cleator GM, Weber T, et al. Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients: European Union Concerted Action on Virus Meningitis and Encephalitis. J Neurovirol. 1998;4:120-132.
59. Gozlan J, Amrani M, Baudrimont M, et al. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegaloviras-related neurological diseases during AIDS. AIDS. 1995;9:253-260.
60. Talpos D, Tien RD, Hesselink JR. Magnetic resonance imaging of AIDS-related polyradiculopathy. Neurology. 1991;41:1995-1997.
61. Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology. 1990;40:569-574.
62. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis. 1993;17:32-37.
63. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000;59:1251-1260.
64. Anders HJ, Weiss N, Bogner JR, Goebel FD. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect. 1998;36:29-33.
65. Behrens GM, Meyer D, Stoll M, Schmidt RE. Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy. Immunobiology. 2000;202:186-193.
66. Powderly WG. Immune reconstitution and the consequences for opportunistic infection treatment and prevention. Curr Infect Dis Rep. 1999;1:99-104.
67. Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS. 1999;13(suppl A):S25-S38.
68. Makela P, Howe L, Glover S, Ferguson I, Pinto A, Gompels M. Recurrent Guillain-Barré syndrome as a complication of immune reconstitution in HIV. J Infect. 2002;44:47-49.
69. Piliero PJ, Fish DG, Preston S, et al. Guillain-Barré syndrome associated with immune reconstitution. Clin Infect Dis. 2003;36:e111-e114.